Early protein restriction in chronic renal failure. 1985

J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker

We performed a prospective randomised trial in 199 patients with various stages of renal failure. Stratified for sex, age and renal insufficiency, 105 patients were assigned to a protein (Pr)-restricted group (0.4-0.6g/kg/BW), and 94 to a control group. Pr-restriction led to a significant reduction in the excretion of urea, phosphate and protein. Survival of renal function was significantly better in Pr-restricted patients. Median serum creatinine concentration increased in the control group (p less than 0.05), but remained stable in Pr-restricted patients. We conclude that Pr-restriction retards, or even halts the progression of chronic renal failure.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004044 Dietary Proteins Proteins obtained from foods. They are the main source of the ESSENTIAL AMINO ACIDS. Proteins, Dietary,Dietary Protein,Protein, Dietary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol

Related Publications

J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker
October 1982, Kidney international,
J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker
June 1991, Hospital practice (Office ed.),
J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker
March 1993, Archives of disease in childhood,
J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker
January 1985, Lancet (London, England),
J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker
February 1987, Lancet (London, England),
J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker
February 1985, Lancet (London, England),
J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker
October 2003, Ugeskrift for laeger,
J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker
January 1989, Blood purification,
J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker
October 2007, The Cochrane database of systematic reviews,
J B Rosman, and P M ter Wee, and G P Piers-Becht, and W J Sluiter, and F J van der Woude, and S Meijer, and A J Donker
November 1992, European journal of clinical nutrition,
Copied contents to your clipboard!